期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Obstetrics and Gynecology. 2022; 2: (4) ; 37-39 ; DOI: 10.12208/j.ijog.20220080.

To explore the clinical effect of treating patients with endometriosis with dinogestrel
探讨子宫内膜异位症患者采用地诺孕素治疗的临床效果

作者: 蔡炳熙 *

河北省馆陶县人民医院 河北邯郸

*通讯作者: 蔡炳熙,单位:河北省馆陶县人民医院 河北邯郸;

发布时间: 2022-12-28 总浏览量: 402

摘要

目的 分析子宫内膜异位症患者采取地诺孕素治疗的效果。方法 以随机数字表法将本院在2020年2月-2021年2月期间收入的子宫内膜异位症患者(n=86)进行分组,其中参考组(n=43)给予桂枝茯苓胶囊治疗,实验组(n=43)在参考组基础上采取地诺孕素治疗。以治疗有效率、性激素水平评价两组治疗效果。结果 实验组治疗有效率高于参考组(P<0.05)。实验组治疗后雌二醇、孕酮、促卵泡生成素指标低于参考组(P<0.05),促黄体生成素指标高于参考组(P<0.05)。结论 在子宫内膜异位症患者治疗中给予地诺孕素治疗效果显著,可提升患者治疗有效率,改善其性激素水平。此种治疗方法值得在临床上推广应用。

关键词: 子宫内膜异位症;地诺孕素;治疗有效率;性激素水平

Abstract

Objective To analyze the effect of denorgestrel on patients with endometriosis.
Methods The patients with endometriosis from February 2020 to February 2021 in our hospital (n=86) were divided into two groups by random number table. The reference group (n=43) was treated with Guizhi Fuling Capsule, and the experimental group (n=43) was treated with Dinogestrel on the basis of the reference group. The therapeutic effect of the two groups was evaluated by the therapeutic efficiency and the level of sex hormone.
Results The effective rate of the experimental group was higher than that of the reference group (P<0.05). After treatment, estradiol, progesterone and follicle stimulating hormone in the experimental group were lower than those in the reference group (P<0.05), while luteinizing hormone was higher than those in the reference group (P<0.05).
Conclusion   In the treatment of patients with endometriosis, the treatment effect of Dinogestrel is significant, which can enhance the treatment efficiency of patients and improve their sex hormone level. This kind of treatment method is worth popularizing and applying in clinic.

Key words: Endometriosis; Dinogestrel; Effective rate of treatment; Sex hormone level

参考文献 References

[1] 黄艳,彭超,周应芳.地诺孕素治疗子宫腺肌病的研究进展[J].中华妇产科杂志,2021,56(12):876-880.

[2] 区瑾华,麦小珊,胡道琴,裴雪梅,何思敏,陈素珍.地诺孕素、左炔诺孕酮宫内节育系统治疗子宫腺肌病的临床对比研究[J].中外医疗,2021,40(29):117-120.

[3] 纪晓,王飞,姜晓媛,邢建红.地诺孕素联合中药治疗子宫内膜异位症的疗效及其对妊娠、复发的影响[J].中国医师进修杂志,2021,44(10):930-934.

[4] 曹啸俊,刘姝灵,陆舜华,孟令宇.地诺孕素对卵巢子宫内膜异位囊肿患者术后复发及卵巢储备功能的影响[J].实用药物与临床,2021,24(09):809-812.

[5] 李吉,曾小龙.地诺孕素治疗对子宫内膜异位症患者的临床疗效探讨[J].世界复合医学,2020,6(12):167-169+173.

[6] 卢娜,张丹,苑文娜.桂枝茯苓胶囊联合地诺孕素治疗子宫内膜异位症的临床研究[J].现代药物与临床,2020,35(06):1117-1121.

[7] 童彦艳,钟惠珍.桂枝茯苓胶囊联合地诺孕素治疗子宫内膜异位症的临床研究[J].现代实用医学,2021,33(09):1196-1198.

[8] 郑韵熹,易晓芳,徐丛剑.地诺孕素在子宫内膜异位症治疗中的应用研究进展[J].中华生殖与避孕杂志,2020,40(10):828-831.

[9] 王晓丽,张红娟,徐梦娟.不同剂量地诺孕素治疗子宫内膜异位症患者的效果及对其CA125、IL-6、TNF-α的影响[J].临床医学工程,2021,28(09):1175-1176.

[10] 黄裕平,柯琪文,范蕾蕾,马利国.地诺孕素治疗子宫内膜异位症的研究进展[J].临床医学研究与实践,2020,5(07):196-198.

引用本文

蔡炳熙, 探讨子宫内膜异位症患者采用地诺孕素治疗的临床效果[J]. 国际妇产科研究, 2022; 2: (4) : 37-39.